Literature DB >> 6029953

An atypical genetic haemorrhagic disease with increased concentration of a natural inhibitor of prothrombin consumption.

A J Robinson, P M Aggeler, G P McNicol, A S Douglas.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6029953     DOI: 10.1111/j.1365-2141.1967.tb00761.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  2 in total

1.  Distribution of antithrombin III and glucosylceramide in human plasma lipoproteins and lipoprotein deficient plasma.

Authors:  S Chatterjee; W R Bell; P O Kwiterovich
Journal:  Lipids       Date:  1984-05       Impact factor: 1.880

2.  Antithrombin III (AT3) polymorphism in the marsupial Monodelphis domestica: identification and genetics.

Authors:  K Bell; H Arthur; R A van Oorschot; J L VandeBerg
Journal:  Biochem Genet       Date:  1992-12       Impact factor: 1.890

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.